Salvadori Daniel Gesua Sive's Form 4 filing
Abbott Laboratories (ABT) · filed Mar 3, 2026
- Accession no.
- 0001620564-26-000007
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $102.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salvadori Daniel Gesua SiveCIK 0001620564 | Officer (EVP AND GROUP PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common shares without par value | FTax withholdingDisposed | −6,615 | $116.26 | −$769,059.9 | 147,262 | Direct | |
| Mar 2, 2026 | Common shares without par value | SSaleDisposed | −885 | $115.58 | −$102,288.3 | 146,377 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.